Explaining the Oncotype DX Test

What is the Oncotype DX test?

1854240173There have been a lot of advancements in the fight against cancer in recent years. The Oncotype DX test is one of those advancements and it has changed the way doctors are fighting the disease. This new test helps doctors get a look at the genetic makeup of your specific cancer. Every cancer responds to treatment in a different way. Doctors use this genetic information to determine which treatments will work best. Dr. Barry Feig discusses more about the Oncotype DX test in this video.

To learn more about the Oncotype DX test watch “Oncotype DX Colon Cancer Treatment Decisions” with Dr. Mark Kozloff.

Video Transcripts

Barry Feig, MD: The Oncotype DX test is a test for evaluating risk assessment in patients with stage 2 colon cancer. We always try to treat patients based on their personal cancer risk and we don’t have consistent ways of measuring risk assessment. The Oncotype DX test is a genomic profiling of the tumor that allows us to get another piece of risk stratification to help us identify how aggressive the tumor is and that helps us tailor treatment strategies after surgery.

This information should not be relied upon as a substitute for personal medical advice, diagnosis or treatment. Use the information provided on this site solely at your own risk. If you have any concerns about your health, please consult with a physician.

© 2022 Cancer Answers LLC